News

Gloucester Marine Genomics Institute (GMGI) Marine Research

Gloucester-Marine-Genomics-Institute-(GMGI)-Research

Roughly 75% of the earth’s surface is covered by water, yet the ocean remains largely unexplored for drug discovery.  Gloucester Marine Genomics Institute (GMGI) scientists are excited to lead the charge in exploring the ocean’s microbiome to provide research to inform treatments – possibly cures – of devastating diseases.  Dr. Andrea Bodnar is here to talk about some of the latest marine research and its look at anti-ageing and human health effects.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Cancer?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Andrea Bodnar, Ph.D. is a Scientist whose research interests lie at the intersection of marine biology and human health. With experience in both academic and industry settings, she brings a unique perspective and broad experience important to establishing a new world-class research institute. Prior to joining GMGI as the Science Director, Andrea was a Senior Scientist in the Molecular Discovery Lab at the Bermuda Institute of Ocean Sciences (BIOS). At BIOS, her research program focused on using sea urchins as models to understand the cellular and molecular mechanisms underlying extreme longevity, negligible ageing and naturally occurring resistance to cancer. Prior to that, Andrea held Senior Scientist positions in the Oncology Department of Hoffman-La Roche, the Department of Cell Biology and Pharmacology at Geron Corporation and the Bioprocessing Technology Institute at the National University of Singapore. She received a BSc and PhD in Biochemistry from McMaster University in Canada and conducted post-doctoral studies in the Department of Neurological Science at the University of London.

Last updated: January 14, 2020

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.